Detalles de la búsqueda
1.
Lower frequencies of circulating suppressive regulatory T cells and higher frequencies of CD4+ naïve T cells at baseline are associated with severe immune-related adverse events in immune checkpoint inhibitor-treated melanoma.
J Immunother Cancer
; 12(1)2024 01 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-38233101
2.
Disrupting CD38-driven T cell dysfunction restores sensitivity to cancer immunotherapy.
bioRxiv
; 2024 Mar 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-38405985
Resultados
1 -
2
de 2
1
Próxima >
>>